No matches

6 search results for: heterogeneity

Confidence Across the Spectrum: Addressing the <b>Heterogeneity</b> of CSU

Dermatology

Confidence Across the Spectrum: Addressing the Heterogeneity of CSU

15 min

Infographic

This infographic explores the heterogeneity of chronic spontaneous urticaria (CSU) across patient subpopulations and highlights differences in demographic and clinical characteristics that may impact disease burden and management.

Chronic Obstructive Pulmonary Disease: Disease Burden & <b>Heterogeneity</b>

Pulmonology

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

5 min

interactivity

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).

<b>Heterogeneity</b> and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU

Dermatology

Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU

10 min

expert video

In this video from EADV 2025, Dr. Netchiporouk discusses the clinical features, diagnosis, and burden of CSU

Pulmonology

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes

5 min

interactivity

This infographic outlines how endotyping, phenotyping, and genotyping are interrelated concepts that are crucial for improving the way patients with COPD are characterized and how understanding these concepts can better optimize patient care

Pulmonology

Dynamic Eosinophils: Decoding Variability in COPD

5 min

interactivity

Explore how blood eosinophil counts can fluctuate over time in patients with COPD and how repeat measurements may help reveal patterns of underlying type 2 inflammation.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: EstoniaChange country/region